Your browser doesn't support javascript.
loading
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817.
Paz-Ares, Luis G; Ciuleanu, Tudor-Eliade; Pluzanski, Adam; Lee, Jong-Seok; Gainor, Justin F; Otterson, Gregory A; Audigier-Valette, Clarisse; Ready, Neal; Schenker, Michael; Linardou, Helena; Caro, Reyes Bernabe; Provencio, Mariano; Zurawski, Bogdan; Lee, Ki Hyeong; Kim, Sang-We; Caserta, Claudia; Ramalingam, Suresh S; Spigel, David R; Brahmer, Julie R; Reck, Martin; O'Byrne, Kenneth J; Girard, Nicolas; Popat, Sanjay; Peters, Solange; Memaj, Arteid; Nathan, Faith; Aanur, Nivedita; Borghaei, Hossein.
Afiliação
  • Paz-Ares LG; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain. Electronic address: lpazaresr@seom.org.
  • Ciuleanu TE; Department of Medical Oncology, Institutul Oncologic Prof. Dr. Ion Chiricuta and University of Medicine and Pharmacy Iulia Hatieganu, Cluj-Napoca, Romania.
  • Pluzanski A; Department of Lung Cancer and Chest Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Lee JS; Department of Hematology/Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.
  • Otterson GA; The Ohio State University-James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Audigier-Valette C; Orientation Oncologique, Hôpital Sainte-Musse, Toulon, France.
  • Ready N; Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
  • Schenker M; Department of Medical Oncology, Sf Nectarie Oncology Center, Craiova, Romania.
  • Linardou H; Fourth Oncology Department and Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece.
  • Caro RB; Medical Oncology Department, Hospital Universitario Virgen Del Rocio, Instituto de Biomedicina de Seville, Seville, Spain.
  • Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Zurawski B; Chemotherapy Department, Ambulatorium Chemioterapii, Bydgoszcz, Poland.
  • Lee KH; Medical Oncology, Chungbuk National University Hospital, Cheongju-si, Republic of Korea.
  • Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Caserta C; Medical Oncology Department, Santa Maria Hospital, Terni, Italy.
  • Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia.
  • Spigel DR; Thoracic Medical Oncology, Sarah Cannon Research Institute/Tennessee Oncology PLLC, Nashville, Tennessee.
  • Brahmer JR; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland.
  • Reck M; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, LungClinic, Grosshansdorf, Germany.
  • O'Byrne KJ; Princess Alexandra Hospital, Translational Research Institute and Queensland University of Technology, Brisbane, Queensland, Australia.
  • Girard N; Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.
  • Popat S; Lung Unit, Royal Marsden Hospital, London, United Kingdom; The Institute of Cancer Research, University of London, London, United Kingdom.
  • Peters S; Oncology Department, Lausanne University Hospital, Lausanne, Switzerland.
  • Memaj A; Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, New Jersey.
  • Nathan F; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain; Medical Oncology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
  • Aanur N; OneClinical, Bristol Myers Squibb, Princeton, New Jersey.
  • Borghaei H; Hematology and Oncology Department, Fox Chase Cancer Center, Temple Health System, Philadelphia, Pennsylvania.
J Thorac Oncol ; 18(1): 79-92, 2023 01.
Article em En | MEDLINE | ID: mdl-36049658
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article